Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Gastric Cancer

  Free Subscription

Articles published in J Cancer Res Clin Oncol

Retrieve available abstracts of 54 articles:
HTML format

Single Articles

    May 2021
  1. XIE J, Pang Y, Li X, Wu X, et al
    The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    J Cancer Res Clin Oncol. 2021 May 18. pii: 10.1007/s00432-021-03654.
    PubMed     Abstract available

  2. LIU Z, Shi M, Li X, Song S, et al
    HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2021;147:1315-1324.
    PubMed     Abstract available

    April 2021
  3. ZHANG Y, Wang F, Sun HR, Huang YK, et al
    Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
    J Cancer Res Clin Oncol. 2021 Apr 23. pii: 10.1007/s00432-021-03633.
    PubMed     Abstract available

  4. WAN Q, Zhao R, Xia L, Wu Y, et al
    Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies.
    J Cancer Res Clin Oncol. 2021;147:1077-1087.
    PubMed     Abstract available

    March 2021
  5. ZHANG Q, Ni Y, Zhi X, Wang J, et al
    Involvement of APRIL in Helicobacter pylori-related gastric cancer.
    J Cancer Res Clin Oncol. 2021 Mar 18. pii: 10.1007/s00432-021-03574.
    PubMed     Abstract available

  6. NA JE, Lee H, Min YW, Min BH, et al
    Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer.
    J Cancer Res Clin Oncol. 2021 Mar 5. pii: 10.1007/s00432-021-03581.
    PubMed     Abstract available

    February 2021
  7. JIANG L, Gong X, Liao W, Lv N, et al
    Molecular targeted treatment and drug delivery system for gastric cancer.
    J Cancer Res Clin Oncol. 2021 Feb 7. pii: 10.1007/s00432-021-03520.
    PubMed     Abstract available

  8. OHNUMA H, Sato Y, Onoyama N, Hamaguchi K, et al
    Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
    J Cancer Res Clin Oncol. 2021 Feb 3. pii: 10.1007/s00432-021-03516.
    PubMed     Abstract available

    January 2021
  9. FAN Y, Liu M, Li S, Yu J, et al
    Surgical and oncological efficacy of laparoscopic-assisted total gastrectomy versus open total gastrectomy for gastric cancer by propensity score matching: a retrospective comparative study.
    J Cancer Res Clin Oncol. 2021 Jan 7. pii: 10.1007/s00432-020-03503.
    PubMed     Abstract available

  10. SUN Y, He J, Shi DB, Zhang H, et al
    Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2021;147:105-115.
    PubMed     Abstract available

    August 2020
  11. JIN P, Ji X, Ma S, Kang W, et al
    Indications for adjuvant chemotherapy in patients with pT1N1M0 gastric cancer: a single-center experience.
    J Cancer Res Clin Oncol. 2020 Aug 9. pii: 10.1007/s00432-020-03355.
    PubMed     Abstract available

  12. MA F, Wang B, Xue L, Kang W, et al
    Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.
    J Cancer Res Clin Oncol. 2020;146:2135-2142.
    PubMed     Abstract available

    July 2020
  13. RAMOS MFKP, Pereira MA, de Castria TB, Ribeiro RRE, et al
    Remnant gastric cancer: a neglected group with high potential for immunotherapy.
    J Cancer Res Clin Oncol. 2020 Jul 15. pii: 10.1007/s00432-020-03322.
    PubMed     Abstract available

  14. JIN P, Ji X, Kang W, Li Y, et al
    Artificial intelligence in gastric cancer: a systematic review.
    J Cancer Res Clin Oncol. 2020 Jul 1. pii: 10.1007/s00432-020-03304.
    PubMed     Abstract available

    May 2020
  15. CHENG L, Chen S, Wu W, Kuo ZC, et al
    Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis.
    J Cancer Res Clin Oncol. 2020 May 25. pii: 10.1007/s00432-020-03268.
    PubMed     Abstract available

    March 2020
  16. XIE W, Zhou H, Han Q, Sun T, et al
    Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes.
    J Cancer Res Clin Oncol. 2020 Mar 6. pii: 10.1007/s00432-020-03171.
    PubMed     Abstract available

    February 2020
  17. LIU X, Lin K, Huang X, Xie W, et al
    Overexpression of the human cytomegalovirus UL111A is correlated with favorable survival of patients with gastric cancer and changes T-cell infiltration and suppresses carcinogenesis.
    J Cancer Res Clin Oncol. 2020 Feb 5. pii: 10.1007/s00432-019-03092.
    PubMed     Abstract available

  18. DONG Y, Qiu Y, Deng J, Wang W, et al
    Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
    J Cancer Res Clin Oncol. 2020;146:515-528.
    PubMed     Abstract available

    January 2020
  19. ZHANG C, Lin X, Zhao Q, Wang Y, et al
    YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
    J Cancer Res Clin Oncol. 2020 Jan 8. pii: 10.1007/s00432-019-03115.
    PubMed     Abstract available

    November 2019
  20. MAEZAWA Y, Sakamaki K, Oue N, Kimura Y, et al
    High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.
    J Cancer Res Clin Oncol. 2019 Nov 21. pii: 10.1007/s00432-019-03087.
    PubMed     Abstract available

  21. CLAUSEN F, Behrens HM, Kruger S, Rocken C, et al
    Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women.
    J Cancer Res Clin Oncol. 2019 Nov 19. pii: 10.1007/s00432-019-03082.
    PubMed     Abstract available

    October 2019
  22. LI Q, Lv M, Jiang H, Wang Y, et al
    A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy.
    J Cancer Res Clin Oncol. 2019 Oct 30. pii: 10.1007/s00432-019-03060.
    PubMed     Abstract available

  23. LI J, Xu H, Zhang L, Song L, et al
    Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening.
    J Cancer Res Clin Oncol. 2019 Oct 9. pii: 10.1007/s00432-019-03004.
    PubMed     Abstract available

  24. KAJTAZI Y, Kaemmerer D, Sanger J, Schulz S, et al
    Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
    J Cancer Res Clin Oncol. 2019;145:2481-2493.
    PubMed     Abstract available

    September 2019
  25. BOSCH F, Todorova R, Link H, Westphalen CB, et al
    Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
    J Cancer Res Clin Oncol. 2019 Sep 20. pii: 10.1007/s00432-019-03029.
    PubMed     Abstract available

  26. XIN L, Zhou Q, Yuan YW, Zhou LQ, et al
    METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy.
    J Cancer Res Clin Oncol. 2019 Sep 4. pii: 10.1007/s00432-019-03015.
    PubMed     Abstract available

    July 2019
  27. PARISI A, Cortellini A, Roberto M, Venditti O, et al
    Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.
    J Cancer Res Clin Oncol. 2019 Jul 6. pii: 10.1007/s00432-019-02971.
    PubMed     Abstract available

  28. HWANG JE, Kim H, Shim HJ, Bae WK, et al
    Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
    J Cancer Res Clin Oncol. 2019 Jul 4. pii: 10.1007/s00432-019-02963.
    PubMed     Abstract available

    March 2019
  29. QIN J, Wang S, Wang P, Wang X, et al
    Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer.
    J Cancer Res Clin Oncol. 2019 Mar 18. pii: 10.1007/s00432-019-02884.
    PubMed     Abstract available

  30. TIAN Y, Jia X, Wang S, Li Y, et al
    Retraction Note to: SOX2 oncogenes amplified and operate to activate AKT signalling in gastric cancer and predict immunotherapy responsiveness.
    J Cancer Res Clin Oncol. 2019 Mar 11. pii: 10.1007/s00432-019-02878.
    PubMed     Abstract available

    January 2019
  31. CHUNG HW, Kim JH, Sung IK, Lee SY, et al
    FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer.
    J Cancer Res Clin Oncol. 2019 Jan 2. pii: 10.1007/s00432-018-02832.
    PubMed     Abstract available

    December 2018
  32. XIE JW, Li P, Wang JB, Lin JX, et al
    Modified AJCC staging of gastric neuroendocrine carcinoma based on T staging can improve the capacity of prognosis assessment.
    J Cancer Res Clin Oncol. 2018;144:2391-2397.
    PubMed     Abstract available

    August 2018
  33. GAO X, Zhang Y, Yuan F, Ding B, et al
    Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy.
    J Cancer Res Clin Oncol. 2018 Aug 9. pii: 10.1007/s00432-018-2728.
    PubMed     Abstract available

    July 2018
  34. QIU J, Li X, He Y, Sun D, et al
    Distinct subgroup of the Ras family member 3 (DIRAS3) expression impairs metastasis and induces autophagy of gastric cancer cells in mice.
    J Cancer Res Clin Oncol. 2018 Jul 24. pii: 10.1007/s00432-018-2708.
    PubMed     Abstract available

    June 2018
  35. HONG HN, Won YJ, Shim JH, Kim HJ, et al
    Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.
    J Cancer Res Clin Oncol. 2018 Jun 12. pii: 10.1007/s00432-018-2683.
    PubMed     Abstract available

  36. LI YF, Zhang HT, Xin L
    Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.
    J Cancer Res Clin Oncol. 2018 Jun 1. pii: 10.1007/s00432-018-2678.
    PubMed     Abstract available

    March 2018
  37. XIAO H, Quan H, Pan S, Yin B, et al
    Impact of peri-operative blood transfusion on post-operative infections after radical gastrectomy for gastric cancer: a propensity score matching analysis focusing on the timing, amount of transfusion and role of leukocyte depletion.
    J Cancer Res Clin Oncol. 2018 Mar 23. pii: 10.1007/s00432-018-2630.
    PubMed     Abstract available

  38. SCHMALENBERG H, Al-Batran SE, Pauligk C, Zander T, et al
    CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.
    J Cancer Res Clin Oncol. 2018;144:559-569.
    PubMed     Abstract available

    February 2018
  39. YE J, Huang Q, Xu J, Huang J, et al
    Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.
    J Cancer Res Clin Oncol. 2018 Feb 12. pii: 10.1007/s00432-018-2605.
    PubMed     Abstract available

    December 2017
  40. LI S, Lan X, Gao H, Li Z, et al
    Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
    J Cancer Res Clin Oncol. 2017;143:2455-2468.
    PubMed     Abstract available

    April 2017
  41. ZHANG S, Shang Y, Chen T, Zhou X, et al
    Human circulating and tissue gastric cancer stem cells display distinct epithelial-mesenchymal features and behaviors.
    J Cancer Res Clin Oncol. 2017 Apr 20. doi: 10.1007/s00432-017-2417.
    PubMed     Abstract available

    March 2017
  42. PAN L, Liang W, Fu M, Huang ZH, et al
    Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
    J Cancer Res Clin Oncol. 2017 Mar 11. doi: 10.1007/s00432-017-2361.
    PubMed     Abstract available

  43. LORDICK F, Al-Batran SE, Dietel M, Gaiser T, et al
    HER2 testing in gastric cancer: results of a German expert meeting.
    J Cancer Res Clin Oncol. 2017 Mar 11. doi: 10.1007/s00432-017-2374.
    PubMed     Abstract available

    February 2017
  44. ZHOU ZH, Ji CD, Zhu J, Xiao HL, et al
    The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer.
    J Cancer Res Clin Oncol. 2017 Feb 8. doi: 10.1007/s00432-017-2346.
    PubMed     Abstract available

    January 2017
  45. LI Y, Wang C, Xu M, Kong C, et al
    Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.
    J Cancer Res Clin Oncol. 2017 Jan 20. doi: 10.1007/s00432-016-2330.
    PubMed     Abstract available

    December 2016
  46. HOU JY, Wang YG, Ma SJ, Yang BY, et al
    Identification of a prognostic 5-Gene expression signature for gastric cancer.
    J Cancer Res Clin Oncol. 2016 Dec 29. doi: 10.1007/s00432-016-2324.
    PubMed     Abstract available

  47. KNEISSL J, Hartmann A, Pfarr N, Erlmeier F, et al
    Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Abstract available

  48. OZE I, Shimada S, Nagasaki H, Akiyama Y, et al
    Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Abstract available

    November 2016
  49. STOLLBERG S, Kammerer D, Neubauer E, Schulz S, et al
    Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.
    J Cancer Res Clin Oncol. 2016;142:2239-47.
    PubMed     Abstract available

    October 2016
  50. CHEN HD, Zhou J, Wen F, Zhang PF, et al
    Cost-effectiveness analysis of apatinib treatment for chemotherapy-refractory advanced gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Abstract available

  51. DING WJ, Zhou M, Chen MM, Qu CY, et al
    HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Abstract available

  52. LIU KT, Wan JF, Yu GH, Bei YP, et al
    The recommended treatment strategy for locally advanced gastric cancer in elderly patients aged 75 years and older: a Surveillance, Epidemiology, and End Results database analysis.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Abstract available

    September 2016
  53. YANG Y, Wang G, He J, Wu F, et al
    Robotic gastrectomy versus open gastrectomy in the treatment of gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Abstract available

    August 2016
  54. LI P, Sun D, Li X, He Y, et al
    Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2016;142:1765-73.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.